RAPID MICRO BIOSYSTEMS, INC.

# Rapid Micro Biosystems, Inc.

Based in Lexington, Massachusetts, this life sciences technology company develops automated microbial detection systems for quality control testing in pharmaceutical, medical device, and personal care manufacturing. The company's primary offering is the Growth Direct platform, which modernizes manual microbial quality control workflows by automating contamination detection across multiple applications including environmental monitoring, water analysis, bioburden testing, and sterility release testing. The platform serves manufacturers of biologics, vaccines, cell and gene therapies, and sterile injectables.

The Growth Direct system comprises hardware instrumentation, proprietary consumables, laboratory information management system connectivity software, and associated validation and support services. The company also offers RMBNucleus Mold Alarm software and provides onsite technical training to customers implementing its solutions.

Rapid Micro Biosystems operates with approximately 163 full-time employees and maintains a geographic presence across the United States, Germany, Switzerland, Japan, and other international markets. The company was incorporated in Delaware in 2006, originally as Genomic Profiling Systems, Inc., before transitioning to its current name and focus on microbial detection technologies. It is publicly traded on the Nasdaq exchange.